LEAN GAIN SARMS 40 mg x 50 Capsules – Huma Peptide

Description

Huma Peptide LEAN GAIN SARMS 40 mg is a premium multi-compound research formulation combining LGD-4033 (Ligandrol), MK-2866 (Ostarine), and Androsta-3,5-diene-7,17-dione (Arimistane) into a single advanced investigational product. Developed exclusively for laboratory research, this formulation enables scientists to investigate the interaction between androgen receptor signaling, steroid metabolism, and endocrine regulation within a comprehensive experimental model.

By integrating two extensively researched Selective Androgen Receptor Modulators (SARMs) with Androsta-3,5-diene-7,17-dione (Arimistane), an investigational steroidal aromatase-modulating compound, LEAN GAIN SARMS provides researchers with a versatile platform for studying androgen receptor activation, steroid hormone metabolism, gene transcription, protein metabolism, cellular differentiation, and endocrine communication. Its complementary pharmacological profile makes it valuable for advanced research in molecular endocrinology, receptor pharmacology, and musculoskeletal biology.

Each bottle contains 50 capsules, delivering a total of 40 mg of active ingredients per capsule, manufactured by Huma Peptide under stringent pharmaceutical-quality standards. Every batch undergoes rigorous quality testing to ensure exceptional purity, formulation consistency, and dependable laboratory performance.

Key Features

• Premium three-compound research formulation
• 40 mg total active ingredients per capsule
• 50 capsules per bottle
• Combines LGD-4033 (Ligandrol), MK-2866 (Ostarine), and Androsta-3,5-diene-7,17-dione (Arimistane)
• Multi-pathway investigational formula for endocrine and musculoskeletal research
• High-purity laboratory-grade formulation
• Extensively researched in androgen receptor biology, steroid metabolism, and molecular endocrinology
• Suitable for investigations involving receptor pharmacology, protein metabolism, gene transcription, cellular differentiation, and endocrine signaling
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

LEAN GAIN SARMS combines three investigational compounds with complementary biological mechanisms, allowing researchers to explore multiple endocrine and anabolic signaling pathways.

• LGD-4033 (Ligandrol) selectively binds to androgen receptors (AR), enabling investigations into tissue-selective signaling, protein metabolism, gene transcription, and musculoskeletal physiology.
• MK-2866 (Ostarine) selectively interacts with androgen receptors, providing an additional model for studying cellular differentiation, receptor pharmacology, and intracellular signaling pathways.
• Androsta-3,5-diene-7,17-dione (Arimistane) is investigated for its role in steroid hormone metabolism and aromatase-related pathways, allowing researchers to examine endocrine regulation and steroidogenic processes in laboratory models.

Together, these complementary mechanisms provide a comprehensive research platform for examining androgen receptor biology, steroid metabolism, endocrine communication, receptor-ligand interactions, and molecular physiology in controlled laboratory environments.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• LGD-4033 (Ligandrol)
• MK-2866 (Ostarine)
• Androsta-3,5-diene-7,17-dione (Arimistane)

Total Active Ingredients: 40 mg per capsule

Packaging: 50 Capsules